118 related articles for article (PubMed ID: 1127989)
1. Biliary bile acid composition in Wilson's disease.
Cowen AE; Korman MG; Hofmann AF; Goldstein NP
Mayo Clin Proc; 1975 May; 50(5):229-33. PubMed ID: 1127989
[TBL] [Abstract][Full Text] [Related]
2. [Aspects of bile acid metabolism in liver diseases(author's transl)].
Horak W
Acta Med Austriaca Suppl; 1975; 4():1-38. PubMed ID: 1064281
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in the bile acid composition of human bile: studies in patients with and without gallstones.
Fisher MM; Yousef IM
Can Med Assoc J; 1973 Aug; 109(3):190-3. PubMed ID: 4728947
[TBL] [Abstract][Full Text] [Related]
4. The nature of the copper complexes in bile and their relationship to the absorption and excretion of copper in normal subjects and in Wilson's disease.
Lewis KO
Gut; 1973 Mar; 14(3):221-32. PubMed ID: 4700437
[TBL] [Abstract][Full Text] [Related]
5. Defective biliary excretion of copper in Wilson's disease.
Frommer DJ
Gut; 1974 Feb; 15(2):125-9. PubMed ID: 4820637
[TBL] [Abstract][Full Text] [Related]
6. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
7. Bile acid metabolism in cirrhosis. IV. Characterization of the abnormality in deoxycholic acid metabolism.
Yoshida T; McCormick WC; Swell L; Vlahcevic ZR
Gastroenterology; 1975 Feb; 68(2):335-41. PubMed ID: 1116679
[TBL] [Abstract][Full Text] [Related]
8. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
[TBL] [Abstract][Full Text] [Related]
9. The fate of labelled bile salts introduced into the colon.
Morris JS; Heaton KW
Scand J Gastroenterol; 1974; 9(1):33-9. PubMed ID: 4453804
[No Abstract] [Full Text] [Related]
10. Metabolism of deoxycholic acid in bile fistula patients.
Hanson RF; Williams G
J Lipid Res; 1971 Nov; 12(6):688-91. PubMed ID: 5124534
[TBL] [Abstract][Full Text] [Related]
11. Studies on biliary bile acid metabolism in hepato-biliary diseases.
Harada T
Gastroenterol Jpn; 1975; 10(2):174-8. PubMed ID: 1234096
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of [14C]cholic acid in fulminant hepatic failure: a prognostic test.
Horak W; Waldram R; Murray-Lyon IM; Schuster E; Williams R
Gastroenterology; 1976 Nov; 71(5):809-13. PubMed ID: 964572
[TBL] [Abstract][Full Text] [Related]
13. Bile acid excretion during drainage of extrahepatic cholestasis with refeeding of bile.
Hedenborg G; Norlander A; Norman A
Scand J Clin Lab Invest; 1982 Nov; 42(7):551-6. PubMed ID: 7156866
[TBL] [Abstract][Full Text] [Related]
14. Defective biliary copper excretion in Wilson's disease: the role of caeruloplasmin.
Davis W; Chowrimootoo GF; Seymour CA
Eur J Clin Invest; 1996 Oct; 26(10):893-901. PubMed ID: 8911863
[TBL] [Abstract][Full Text] [Related]
15. Wilson's disease: a new gene and an animal model for an old disease.
Cuthbert JA
J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
[TBL] [Abstract][Full Text] [Related]
16. Plasma disappearance of radioactivity after intravenous injection of labeled bile acids in man.
Cowen AE; Korman MG; Hofmann AF; Thomas PJ
Gastroenterology; 1975 Jun; 68(6):1567-73. PubMed ID: 1132636
[TBL] [Abstract][Full Text] [Related]
17. Effect of bile acid conjugation pattern on bile acid metabolism in normal humans.
Hardison WG; Grundy SM
Gastroenterology; 1983 Mar; 84(3):617-20. PubMed ID: 6822329
[TBL] [Abstract][Full Text] [Related]
18. Validity and sensitivity of an intravenous bile acid tolerance test in patients with liver disease.
LaRusso NF; Hoffman NE; Hofmann AF; Korman MG
N Engl J Med; 1975 Jun; 292(23):1209-14. PubMed ID: 1128572
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of radiocopper into ceruloplasmin in normal subjects and in patients with primary biliary cirrhosis and Wilson's disease.
Vierling JM; Shrager R; Rumble WF; Aamodt R; Berman MD; Jones EA
Gastroenterology; 1978 Apr; 74(4):652-60. PubMed ID: 631501
[No Abstract] [Full Text] [Related]
20. Biliary lipids, faecal steroids, and liver function in patients with chronic active hepatitis and primary biliary cirrhosis: significance of hepatic orcein-stained complexes.
Kesäniemi YA; Miettinen TA; Salaspuro MP
Gut; 1981 Jul; 22(7):579-84. PubMed ID: 6167493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
